CXCR3-positive T cells are increased in the blood of patients with multiple sclerosis (MS), and its ligand CXCL10 is expressed by astrocytes in MS brain lesions, suggesting that CXCR3 may be involved in the immune response and lesion development in MS (Zhou et al., 2019). Here, CXCL10 is linked to myeloid sarcoma.